Task: Answer the multiple-choice question.
Query: Which compound exhibits a 30.040% hERG inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, c, or d without using any additional words.
Options:
a: Cc1ccc2nc(N3C(=O)CNC3=S)sc2c1
b: COc1ccc(S(=O)(=O)N2CCC(O)(c3ccc(Cl)cc3)CC2)cc1
c: CC(=O)Nc1ccc(S(=O)(=O)Nc2nccs2)cc1
d: CCN(CC)CC1CCCCN1CC(=O)N1c2ccccc2C(=O)Nc2cccnc21
Answer: a. Cc1ccc2nc(N3C(=O)CNC3=S)sc2c1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1ccc2nc(N3C(=O)CNC3=S)sc2c1
Cc1ccc2nc(N3C(=O)CNC3=S)sc2c1
3-(6-methyl-1,3-benzothiazol-2-yl)-2-sulfanylideneimidazolidin-4-one